miR‐143 suppresses epithelial–mesenchymal transition and inhibits tumor growth of breast cancer through down‐regulation of ERK5

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular Carcinogenesis

• Publication date

  2016-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.22445PMID 26618772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β‐catenin pathway

  2015cited by this paper
• MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments

  2015cited by this paper
• Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring

  2015cited by this paper
• Withaferin A inhibits experimental epithelial–mesenchymal transition in MCF‐10A cells and suppresses vimentin protein level in vivo in breast tumors

  2015cited by this paper
• miR-153 inhibits epithelial–mesenchymal transition by targeting metadherin in human breast cancer

  2015cited by this paper
• Small molecule compounds targeting miRNAs for cancer therapy.

  2015cited by this paper
• Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2

  2015cited by this paper
• GSK-3 as potential target for therapeutic intervention in cancer

  2014cited by this paper
• MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma

  2014cited by this paper
• The extracellular matrix modulates the hallmarks of cancer

  2014cited by this paper
• Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma

  2014cited by this paper
• Abstract IA09: Copper is required for oncogenic BRAF signaling and tumorigenesis

  2014cited by this paper
• β1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGFβ–miR-200–ZEB Network in E-Cadherin–Positive Triple-Negative Breast Cancer

  2014cited by this paper
• Pluripotent stem cell miRNAs and metastasis in invasive breast cancer.

  2014cited by this paper
• Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma.

  2014cited by this paper
• Copper is required for oncogenic BRAF signaling and tumorigenesis

  2014cited by this paper
• MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis

  2013cited by this paper
• Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72.

  2013cited by this paper
• Galectin-3 Silencing Inhibits Epirubicin-Induced ATP Binding Cassette Transporters and Activates the Mitochondrial Apoptosis Pathway via β-Catenin/GSK-3β Modulation in Colorectal Carcinoma

  2013cited by this paper
• ERK5: structure, regulation and function.

  2012cited by this paper
• To differentiate or not — routes towards metastasis

  2012cited by this paper
• MEK5/ERK5 pathway: the first fifteen years.

  2012cited by this paper
• MicroRNAs and breast cancer malignancy: An overview of miRNA-regulated cancer processes leading to metastasis

  2012cited by this paper
• Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity

  2011cited by this paper
• miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS

  2010cited by this paper
• Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells

  2010cited by this paper
• miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice

  2009cited by this paper
• Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion.

  2009cited by this paper
• Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation

  2008cited by this paper

• Hypoxic breast cancer cell-derived exosomal miR-143-3p targets RICTOR to regulate M2 macrophage polarization, thereby modulating cancer cell invasiveness

  2025cites this paper
• Is the MAPK ERK5 the nexus from FAO to NK cell-mediated metastasis immune surveillance?

  2025cites this paper
• Regulation of cell migration, proliferation, and apoptosis through Psidium guajava extract against breast cancer: Cross-talk of AKT/FOXO3 and MAPK cascade and related miRNAs

  2025cites this paper
• MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways

  2024cites this paper
• Bone and Extracellular Signal-Related Kinase 5 (ERK5)

  2024cites this paper
• Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer

  2023cites this paper
• HetFCM: functional co-module discovery by heterogeneous network co-clustering

  2023cites this paper
• Restoration of miR-143 reduces migration and proliferation of bladder cancer cells by regulating signaling pathways involved in EMT.

  2022cites this paper
• Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression

  2022influential citation
• Effect of Extracellular Signal-Regulated Protein Kinase 5 Inhibition in Clear Cell Renal Cell Carcinoma

  2022cites this paper
• Clinical Significance and Regulation of ERK5 Expression and Function in Cancer

  2022cites this paper
• A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer

  2021cites this paper
• Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer

  2021cites this paper
• Suspension state and shear stress enhance breast tumor cells EMT through YAP by microRNA-29b

  2021cites this paper
• Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling

  2021cites this paper
• Hsa-miRNA-143-3p Regulates Differentiation of Human Stem Cells From The Apical Papilla Through Targeting Nuclear Factor I-C

  2020cites this paper
• Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.

  2020cites this paper
• Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1

  2020cites this paper
• Effects of MIR143 on rat sarcoma signaling networks in solid tumors: A brief overview

  2020cites this paper
• ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer

  2020cites this paper
• miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro.

  2020cites this paper
• High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer

  2020cites this paper
• The Emerging Roles of Exosomes as EMT Regulators in Cancer

  2020cites this paper
• The Microrna-143/145 Cluster in Tumors: A Matter of Where and When

  2020cites this paper
• Transforming growth factor‑β/miR‑143‑3p/cystatin B axis is a therapeutic target in human ovarian cancer.

  2019cites this paper
• Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis.

  2019cites this paper
• Impact of ERK5 on the Hallmarks of Cancer

  2019cites this paper
• The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility

  2019cites this paper
• miR‐143 inhibits proliferation and metastasis of nasopharyngeal carcinoma cells via targeting FMNL1 based on clinical and radiologic findings

  2019cites this paper
• Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer

  2019cites this paper
• Long noncoding RNA HAGLR acts as a microRNA‐143‐5p sponge to regulate epithelial‐mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3

  2019cites this paper
• MicroRNA-143-3p targets pyruvate carboxylase expression and controls proliferation and migration of MDA-MB-231 cells.

  2019cites this paper
• Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes

  2018cites this paper
• miR-185-5p inhibits F-actin polymerization and reverses epithelial mesenchymal transition of human breast cancer cells by modulating RAGE

  2018cites this paper
• Downregulation of miR‐3127‐5p promotes epithelial‐mesenchymal transition via FZD4 regulation of Wnt/β‐catenin signaling in non‐small‐cell lung cancer

  2018cites this paper
• miR-425 suppresses EMT and inhibits the development of TNBC (triple-negative breast cancer) by targeting TGF-β 1/SMAD 3 signaling pathway

  2018cites this paper
• miR-425 suppresses EMT and the development of TNBC (triple-negative breast cancer) by targeting the TGF-β 1/SMAD 3 signaling pathway

  2018cites this paper
• miR‐143 targets MAPK7 in CHO cells and induces a hyperproductive phenotype to enhance production of difficult‐to‐express proteins

  2017cites this paper
• miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6

  2017cites this paper
• Screening and confirmation of microRNA markers for distinguishing between menstrual and peripheral blood.

  2017cites this paper
• Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.

  2017cites this paper
• Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease

  2017cites this paper
• ERK5 Expression in Brain Tumours

  2017cites this paper
• The "good-cop bad-cop" TGF-beta role in breast cancer modulated by non-coding RNAs.

  2017cites this paper
• LncRNA UCA1 promotes the invasion and EMT of bladder cancer cells by regulating the miR-143/HMGB1 pathway.

  2017cites this paper
• MicroRNAs regulate the epithelial–mesenchymal transition and influence breast cancer invasion and metastasis

  2017cites this paper
• miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells.

  2017cites this paper
• cfa-miR-143 Promotes Apoptosis via the p53 Pathway in Canine Influenza Virus H3N2-Infected Cells

  2017cites this paper
• MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2

  2017cites this paper
• LncRNA UCA 1 promotes the invasion and EMT of bladder cancer cells by regulating the miR ‐ 143 / HMGB 1 pathway

  2017cites this paper
• Senescence-Associated MicroRNAs.

  2017cites this paper
• MicroRNA-143 inhibits cell growth by targeting ERK5 and MAP3K7 in breast cancer

  2017cites this paper
• A Functional rs353293 Polymorphism in the Promoter of miR-143/145 Is Associated with a Reduced Risk of Bladder Cancer

  2016cites this paper
• MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.

  2016cites this paper
• MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer.

  2016cites this paper
• Susceptibility of microRNAs 145, 143 and 133b to epigenetic regulation in colorectal cancer cell lines; prediction and functional analysis of putative targets to associated microRNAs

  2016cites this paper
• MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5.

  2016cites this paper